{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:35:04Z","timestamp":1786534504707,"version":"build-2736575974"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast and ovarian cancers represent the major contributors to cancer-related mortality among women globally. To overcome chemoresistance and other mechanisms of therapeutic escape, kaempferol- a dietary flavonoid present in fruits and vegetables- has gained attention for its marked anticancer, anti-inflammatory, and antioxidant activities, positioning it as a promising therapeutic candidate. Preclinical studies indicate that kaempferol exerts multiple antitumour effects by promoting ROS generation, inducing DNA damage, upregulating pro-apoptotic and downregulating anti-apoptotic proteins, triggering G2\/M phase cell-cycle arrest, inhibiting angiogenesis, suppressing epithelial-to-mesenchymal transitions, and reversing chemoresistance in both breast and ovarian cancers. When combined with conventional chemotherapeutic agents, kaempferol has shown potential to inhibit tumour growth and progression. However, despite promising preclinical studies, the molecular mechanism underlying it remains incompletely understood, and clinical evidence on its therapeutic efficacy is still limited. This review critically examines the current literature on kaempferol-mediated anticancer mechanisms in breast and ovarian cancers, evaluates its potential role in combination therapy, and outlines the key challenges and future directions required for translating these findings into clinical applications.<\/jats:p>","DOI":"10.3389\/fonc.2026.1880434","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T10:57:50Z","timestamp":1786532270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting the mechanistic actions of kaempferol in breast and ovarian cancers: pathway-level insights and translational potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Rehana","family":"K.","sequence":"first","affiliation":[{"name":"Department of Integrative Biology, School of Bioscience and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnikrishnan","family":"B. S.","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Dalhousie University","place":["Halifax, NS, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Bio Medical Sciences, School of Bioscience and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syama","family":"H. P.","sequence":"additional","affiliation":[{"name":"Department of Integrative Biology, School of Bioscience and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.25881","article-title":"Analysis of breast cancer mortality in the US\u20141975 to 2019","volume":"331","author":"Caswell-Jin","year":"2024","journal-title":"Jama"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"Ca"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra012284","article-title":"Breast and ovarian cancer","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104081","article-title":"Risk factors for developing both primary breast and primary ovarian cancer: A systematic review","volume":"190","author":"Ferris","year":"2023","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittmore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: a systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J Natl Cancer Institute"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2023.100167","article-title":"Flavonoids as promising molecules in the cancer therapy: An insight","volume":"6","author":"Mir","year":"2024","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081642","article-title":"A critical review of kaempferol in intestinal health and diseases","volume":"12","author":"Chen","year":"2023","journal-title":"Antioxidants"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"B13","article-title":"Nervous system","volume-title":"Cancer Epidemiology and Prevention","author":"Amirian","year":"2018"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.29289\/25945394202020200024","article-title":"Histological and molecular classification of breast cancer: what do we know","volume":"30","author":"GomesDoNascimento","year":"2020","journal-title":"Mastology"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-breast-cancer-etiology","article-title":"The etiology of breast cancer","author":"Admoun","year":"2022"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.12.005","article-title":"Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update","volume":"9","author":"Mohanty","year":"2022","journal-title":"Genes Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.67.1487","article-title":"Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology Guideline","volume":"34","author":"Rugo","year":"2016","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-024-00565-1","article-title":"HER2-targeted therapies in cancer: a systematic review","volume":"12","author":"Zhu","year":"2024","journal-title":"biomark Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.20944\/preprints202306.0074.v1","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.936","article-title":"The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer","volume":"5","author":"Mazidimoradi","year":"2022","journal-title":"Health Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092230","article-title":"Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu Rev Pathology: Mech Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO classification of female genital tumors","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J Natl Compr Cancer Network"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2560","article-title":"Ovarian cancer: Current status and strategies for improving therapeutic outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.08.013","article-title":"New approaches for targeting platinum-resistant ovarian cancer","volume":"77","author":"McMullen","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.04.035","article-title":"Significance of cyclooxygenase 2 and MDR1\/P-glycoprotein coexpression in ovarian cancers","volume":"235","author":"Surowiak","year":"2006","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-09-3427","article-title":"Identification of hypermethylated genes associated with cisplatin resistance in human cancers","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152392","article-title":"The anticancer effects and therapeutic potential of kaempferol in triple-negative breast cancer","volume":"16","author":"Kaur","year":"2024","journal-title":"Nutrients"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5b01639","article-title":"Soy leaf extract containing kaempferol glycosides and pheophorbides improves glucose homeostasis by enhancing pancreatic \u03b2-cell function and suppressing hepatic lipid accumulation in db\/db mice","volume":"63","author":"Li","year":"2015","journal-title":"J Agric Food Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071751","article-title":"Antiulcer agents: From plant extracts to phytochemicals in healing promotion","volume":"23","author":"Sharifi-Rad","year":"2018","journal-title":"Molecules"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6227","article-title":"Chemo\u2010preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review","volume":"33","author":"Imran","year":"2019","journal-title":"Phytother Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1511.11054","article-title":"Kaempferol activates G2-checkpoint of the cell cycle resulting in G2-arrest and mitochondria-dependent apoptosis in human acute leukemia Jurkat T cells","volume":"26","author":"Kim","year":"2016","journal-title":"J Microbiol Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22044","article-title":"Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction","volume":"106","author":"Marfe","year":"2009","journal-title":"J Cell Biochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27248864","article-title":"Therapeutic importance of kaempferol in the treatment of cancer through the modulation of cell signalling pathways","volume":"27","author":"Qattan","year":"2022","journal-title":"Molecules"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.3390\/molecules25184073","article-title":"Kaempferol as a dietary anti-inflammatory agent: current therapeutic standing","volume":"25","author":"Alam","year":"2020","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315054","article-title":"Kaempferol: Antimicrobial properties, sources, clinical, and traditional applications","volume":"23","author":"Periferakis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2012.11.139","article-title":"A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention","volume":"138","author":"Chen","year":"2013","journal-title":"Food Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.05.002","article-title":"Kaempferol and inflammation: From chemistry to medicine","volume":"99","author":"Devi","year":"2015","journal-title":"Pharmacol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076393","article-title":"Antiproliferative mechanisms of a polyphenolic combination of kaempferol and fisetin in triple-negative breast cancer cells","volume":"24","author":"Afzal","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s43450-022-00290-6","article-title":"The potential clinical uses and nanoformulation strategies of kaempferol, a dietary flavonoid","volume":"32","author":"Chandekar","year":"2022","journal-title":"Rev Bras Farmacogn"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202403201","article-title":"Chondroitin sulfate\u2010modified hydroxyapatite for caspase\u20101 activated induced pyroptosis through Ca overload\/ER stress\/STING\/IRF3 pathway in colorectal cancer","volume":"20","author":"Chen","year":"2024","journal-title":"Small"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s209773","article-title":"Kaempferol conjugated gold nanoclusters enabled efficient for anticancer therapeutics to A549 lung cancer cells","volume":"14","author":"Govindaraju","year":"2019","journal-title":"Int J Nanomed"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121080","article-title":"CaCO3 nanoparticles incorporated with KAE to enable amplified calcium overload cancer therapy","volume":"277","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113309","article-title":"Development, characterization and in vitro cytotoxicity of kaempferol-loaded nanostructured lipid carriers in glioblastoma multiforme cells","volume":"226","author":"Nicoleti","year":"2023","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"B51","doi-asserted-by":"publisher","first-page":"30441","DOI":"10.1038\/s41598-025-14435-9","article-title":"Role of CD133 antibody-conjugated nanocarrier in enhancing the targetability of hepatocellular carcinoma stem cells","volume":"15","author":"Aglan","year":"2025","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-023-01357-0","article-title":"Preparation, characterization, and evaluation of the antitumor effect of kaempferol nanosuspensions","volume":"13","author":"He","year":"2023","journal-title":"Drug Delivery Trans Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122086","article-title":"Formulation and evaluation of kaempferol loaded nanoparticles against experimentally induced hepatocellular carcinoma: in vitro and in vivo studies","volume":"13","author":"Kazmi","year":"2021","journal-title":"Pharmaceutics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jnutbio.2015.09.027","article-title":"Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models","volume":"28","author":"Kim","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/bf02968584","article-title":"Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells","volume":"29","author":"Oh","year":"2006","journal-title":"Arch Pharmacal Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcp.10398","article-title":"Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol","volume":"198","author":"Hung","year":"2004","journal-title":"J Cell Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2015.1002625","article-title":"The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake","volume":"67","author":"Azevedo","year":"2015","journal-title":"Nutr Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7067","article-title":"The flavonoid, kaempferol\u20103\u2010O\u2010apiofuranosyl\u20107\u2010O\u2010rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function","volume":"35","author":"Harrath","year":"2021","journal-title":"Phytother Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.847113","article-title":"Interactions between natural products and tamoxifen in breast cancer: a comprehensive literature review","volume":"13","author":"Yen","year":"2022","journal-title":"Front Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109086","article-title":"The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer","volume":"117","author":"Wang","year":"2019","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s140886","article-title":"Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1","volume":"10","author":"Li","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-025-00407-6","article-title":"Targeting the MAPK signaling pathway: Implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients","volume":"16","author":"Kubatka","year":"2025","journal-title":"EPMA J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156701","article-title":"Kaempferol targets Src to exert its chemopreventive effects on mammary tumorigenesis via regulation of the PI3K\/AKT pathway: phytomedicine","volume":"141","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.etap.2016.11.016","article-title":"Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells","volume":"49","author":"Lee","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24122277","article-title":"Kaempferol: A key emphasis to its anticancer potential","volume":"24","author":"Imran","year":"2019","journal-title":"Molecules"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.12659\/msm.915642","article-title":"IQ motif containing GTPase-activating protein 3 (IQGAP3) inhibits kaempferol-induced apoptosis in breast cancer cells by extracellular signal-regulated kinases 1\/2 (ERK1\/2) signaling activation","volume":"25","author":"Hu","year":"2019","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084411","article-title":"Molecular pathways involved in the anti-cancer activity of flavonols: a focus on myricetin and kaempferol","volume":"23","author":"Felice","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.08.061","article-title":"Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study","volume":"140","author":"Sinha","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3727\/096504018x15228018559434","article-title":"Kaempferol suppresses proliferation and induces cell cycle arrest, apoptosis, and DNA damage in breast cancer cells","volume":"27","author":"Zhu","year":"2019","journal-title":"Oncol Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4162\/nrp.2008.2.4.322","article-title":"Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells","volume":"2","author":"Choi","year":"2008","journal-title":"Nutr Res Pract"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2174\/1570163816666190823135948","article-title":"Kaempferol as a potential PAK4 inhibitor in triple negative breast cancer: extra precision glide docking and free energy calculation","volume":"17","author":"Arowosegbe","year":"2020","journal-title":"Curr Drug Discov Technol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.1027.65.3","article-title":"Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation","volume":"65","author":"Smith","year":"2005","journal-title":"Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2017.160","article-title":"Treatment with phytoestrogens reversed triclosan and bisphenol A-induced anti-apoptosis in breast cancer cells","volume":"26","author":"Lee","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1139\/bcb-2014-0067","article-title":"Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9","volume":"93","author":"Li","year":"2015","journal-title":"Biochem Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030367","article-title":"The role of epigenetic modifications in human cancers and the use of natural compounds as epidrugs: mechanistic pathways and pharmacodynamic actions","volume":"12","author":"Bouyahya","year":"2022","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10384-x","article-title":"Kaempferol and apigenin suppresses the stemness properties of TNBC cells by modulating sirtuins","volume":"26","author":"Sharma","year":"2022","journal-title":"Mol Divers"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2012.07.001","article-title":"Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases","volume":"24","author":"Berger","year":"2013","journal-title":"J Nutr Biochem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154029","article-title":"Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways","volume":"237","author":"Nandi","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115887","article-title":"Deregulation of the CD44-NANOG-MDR1-associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of kaempferol in synergism with verapamil","volume":"437","author":"Nandi","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1462823","article-title":"Sea buckthorn and its flavonoids isorhamnetin, quercetin, and kaempferol favorably influence bone and breast tissue health","volume":"15","author":"Martiniakova","year":"2024","journal-title":"Front Pharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7838","article-title":"Kaempferol induces mitochondrial dysfunction and mitophagy by activating the LKB1\/AMPK\/MFF pathway in breast precancerous lesions","volume":"37","author":"Cao","year":"2023","journal-title":"Phytother Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2010.08.010","article-title":"Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor \u03b1 expression in human breast cancer cells","volume":"299","author":"MacPherson","year":"2010","journal-title":"Cancer Lett"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2018.10.121","article-title":"Comparative cytotoxic activity between kaempferol and gallic acid against various cancer cell lines","volume":"21","author":"Pham","year":"2018","journal-title":"Data Brief"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.15.6317","article-title":"Inhibitory aromatase effects of flavonoids from Ginkgo biloba extracts on estrogen biosynthesis","volume":"16","author":"Park","year":"2015","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.596","article-title":"Kaempferol-3-O-rhamnoside isolated from the leaves of Schima wallichii Korth. inhibits MCF-7 breast cancer cell proliferation through activation of the caspase cascade pathway","volume":"3","author":"Diantini","year":"2012","journal-title":"Oncol Lett"},{"key":"B88","doi-asserted-by":"publisher","first-page":"732980","DOI":"10.1155\/2014\/732980","article-title":"Cytotoxic activities against breast cancer cells of local Justicia gendarussa crude extracts","volume":"2014","author":"Ayob","year":"2014","journal-title":"Evidence\u2010Based Complementary Altern Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.21010\/ajtcam.v13i4.27","article-title":"Kaempferol, a flavonoid compound from gynura medica induced apoptosis and growth inhibition in mcf-7 breast cancer cell","volume":"13","author":"Yi","year":"2016","journal-title":"Afr J Traditional Complementary Altern Medicines"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1515\/1553-3840.1644","article-title":"Comparison of effectiveness in antitumor activity between flavonoids and polyphenols of the methanolic extract of roots of Potentilla fulgens in breast cancer cells","volume":"9","author":"Radhika","year":"2012","journal-title":"J Complementary Integr Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-014-9723-2","article-title":"Phytochemical study, cytotoxic, analgesic, antipyretic and anti-inflammatory activities of Strychnos nux-vomica","volume":"67","author":"Eldahshan","year":"2015","journal-title":"Cytotechnology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/01635580802666281","article-title":"Kaempferol inhibits angiogenesis and VEGF expression through both HIF-dependent and independent pathways in human ovarian cancer cells","volume":"61","author":"Luo","year":"2009","journal-title":"Nutr Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2011.07.045","article-title":"Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NF\u03baB-cMyc-p21 pathway","volume":"130","author":"Luo","year":"2012","journal-title":"Food Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2011.03.073","article-title":"Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway","volume":"128","author":"Luo","year":"2011","journal-title":"Food Chem"},{"key":"B95","article-title":"Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0\/G1 cell cycle arrest and modulation of MEK\/ERK and STAT3 pathways","volume":"24","author":"Yang","year":"2019","journal-title":"J Buon"},{"key":"B96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14712\/fb2020066010036","article-title":"Kaempferol induces cell death in A2780 ovarian cancer cells and increases their sensitivity to cisplatin by activation of cytotoxic endoplasmic reticulum-mediated autophagy and inhibition of protein kinase B","volume":"66","author":"El-Kott","year":"2020","journal-title":"Folia Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.12659\/msm.903552","article-title":"Kaempferol sensitizes human ovarian cancer cells-OVCAR-3 and SKOV-3 to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis via JNK\/ERK-CHOP pathway and up-regulation of death receptors 4 and 5","volume":"23","author":"Zhao","year":"2017","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-10-16","article-title":"Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc","volume":"10","author":"Luo","year":"2010","journal-title":"Cancer Cell Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051095","article-title":"Kaempferol induces G2\/M cell cycle arrest via checkpoint kinase 2 and promotes apoptosis via death receptors in human ovarian carcinoma A2780\/CP70 cells","volume":"23","author":"Gao","year":"2018","journal-title":"Molecules"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.53555\/ajbr.v28i1s.6286","article-title":"Comprehensive pharmacological network analysis of kaempferol targeting proteins in breast cancer pathways for receptive therapy","volume":"28","author":"Patra","year":"2025","journal-title":"Afr J Biomed Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-025-03541-9","article-title":"Kaempferols from EChinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach","volume":"16","author":"Usin","year":"2025","journal-title":"Discover Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/2314808x.2023.2272385","article-title":"Computational examination to reveal kaempferol as the most potent active compound from Euphorbia hirta against breast cancer by targeting AKT1 and ER\u03b1","volume":"10","author":"Widyananda","year":"2023","journal-title":"Egypt J Basic Appl Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.593","article-title":"Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4\u2010hydroxytamoxifen, after oral administration of tamoxifen to rats","volume":"29","author":"Piao","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"B104","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12885-017-3440-0","article-title":"The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole","volume":"17","author":"George","year":"2017","journal-title":"BMC Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1055\/a-2637-1672","article-title":"Synergistic induction of apoptosis and cell cycle arrest against breast cancer cells by combined kaempferol and paclitaxel","volume":"75","author":"Aghazadeh","year":"2025","journal-title":"Drug Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114087","article-title":"Kaempferol attenuates doxorubicin-induced renal tubular injury by inhibiting ROS\/ASK1-mediated activation of the MAPK signaling pathway","volume":"157","author":"Wu","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0959-8049(02)00532-4","article-title":"Calcium channel blockers, verapamil and cancer risk","volume":"39","author":"La Vecchia","year":"2003","journal-title":"Eur J Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154689","article-title":"Kaempferol with verapamil impeded panoramic chemoevasion pathways in breast cancer through ROS overproduction and disruption of lysosomal biogenesis","volume":"113","author":"Nandi","year":"2023","journal-title":"Phytomedicine"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09645-0","article-title":"Amlodipine and verapamil, voltage-gated Ca2+ channel inhibitors, suppressed the growth of gastric cancer stem cells","volume":"28","author":"Atsushi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.1038\/s41598-025-07221-0","article-title":"The apoptotic and anti-metastatic effects of niosome kaempferol in MCF-7 breast cancer cells","volume":"15","author":"Minaei","year":"2025","journal-title":"Sci Rep"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117109","article-title":"Green synthesis of chitosan\/silver nanocomposite using kaempferol for triple negative breast cancer therapy and antibacterial activity","volume":"238","author":"Bharathi","year":"2023","journal-title":"Environ Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09205063.2025.2510441","article-title":"Nanostructured solid lipid for paclitaxel and kaempferol co-delivery as a novel synergistic approach for breast cancer","volume":"36","author":"Dewangan","year":"2025","journal-title":"J Biomater Sci Polym Ed"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2018.09.003","article-title":"Catalytic, antioxidant and anticancer activities of gold nanoparticles synthesized by kaempferol glucoside from Lotus leguminosae","volume":"13","author":"Oueslati","year":"2020","journal-title":"Arabian J Chem"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2023.2268739","article-title":"The folate-linked chitosan-coated kaempferol\/HSA nano-transporters (FCKH-NTs) as the selective apoptotic inducer in human MCF-7 breast cancer cell line","volume":"49","author":"Mollaei","year":"2023","journal-title":"Drug Dev Ind Pharm"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0379","article-title":"A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer","volume":"14","author":"Moore","year":"2017","journal-title":"Future Oncol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.5c00391","article-title":"Kaempferol\u2013iron assembled nanoparticles for synergistic photothermal and chemodynamic therapy of breast cancer","volume":"36","author":"Yang","year":"2025","journal-title":"Bioconjugate Chem"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s33670","article-title":"Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability","volume":"7","author":"Luo","year":"2012","journal-title":"Int J Nanomed"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.3499","article-title":"A randomised, placebo\u2010controlled trial evaluating the safety of excessive administration of kaempferol aglycone","volume":"11","author":"Akiyama","year":"2023","journal-title":"Food Sci Nutr"},{"key":"B120","doi-asserted-by":"publisher","first-page":"896","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines","volume":"17","author":"Armstrong","year":"2019","journal-title":"J Natl Compr Cancer Network"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2015.1036739","article-title":"Emerging therapies: angiogenesis inhibitors for ovarian cancer","volume":"20","author":"Jackson","year":"2015","journal-title":"Expert Opin Emerging Drugs"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"Van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.004","article-title":"The forefront of ovarian cancer therapy: update on PARP inhibitors","volume":"31","author":"Mirza","year":"2020","journal-title":"Ann Oncol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00347-4","article-title":"PARP inhibitors and the evolving landscape of ovarian cancer management: a review","volume":"33","author":"Cook","year":"2019","journal-title":"BioDrugs"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1880434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T10:57:52Z","timestamp":1786532272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1880434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":125,"alternative-id":["10.3389\/fonc.2026.1880434"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1880434","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1880434"}}